Makoto Takeda - Infectious Diseases

Author Information

Makoto Takeda is a renowned researcher affiliated with the Department of Virology 3 at the National Institute of Infectious Diseases in Musashimurayama, Tokyo, Japan. His work primarily focuses on infectious diseases, with a specific interest in virology. His research aims to enhance understanding of viral infections and improve public health outcomes.

Research Contributions

Makoto Takeda has made significant contributions to the field of infectious diseases, particularly in understanding respiratory viruses such as Respiratory Syncytial Virus (RSV) and SARS-CoV-2. In 2022 alone, he published several papers examining the thermal stability of RSV, the efficacy of antiviral drugs against COVID-19 variants, and the clinical characteristics of infections in children. His work also spans the study of human coronavirus, measles, rubella immunity, and vaccine management. His research has been instrumental in advancing knowledge of viral pathogenesis and developing effective antiviral strategies.

Aliases

Makoto Takeda is also known in academic circles by the aliases M Takeda and M. Takeda.

Publication and Citation Metrics

Metric	Value
Total Citation Count	12,427
H-index	55
Total Paper Count	256

Publications:

Variation in Thermal Stability among Respiratory Syncytial Virus Clinical Isolates under Non-Freezing Conditions

DOI: 10.3390/v14040679

Year: 2022

Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant

DOI: 10.1056/NEJMc2119407

Year: 2022

Epidemiological and clinical characteristics of infections with seasonal human coronavirus and respiratory syncytial virus in hospitalized children immediately before the coronavirus disease 2019 pandemic

DOI: 10.1016/j.jiac.2022.03.001

Year: 2022

Thirteen Nearly Complete Genome Sequences of Human Bocavirus 1 Isolated from Pediatric Inpatients in Fukushima, Japan

DOI: 10.1128/mra.01027-21

Year: 2022

Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2

DOI: 10.1056/NEJMc2201933

Year: 2022

Effectiveness of immunization activities on measles and rubella immunity among individuals in East Sepik, Papua New Guinea: A cross-sectional study

DOI: 10.1016/j.ijregi.2022.03.001

Year: 2022

Detection of the ORF1 Gene Is an Indicator of the Possible Isolation of Severe Acute Respiratory Syndrome Coronavirus 2

DOI: 10.3390/pathogens11030302

Year: 2022

Identification of anti-severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) oxysterol derivatives in vitro

DOI: 10.1101/2021.01.31.429001

Year: 2021

The Physiological TMPRSS2 Inhibitor HAI-2 Alleviates SARS-CoV-2 Infection

DOI: 10.1128/JVI.00434-21

Year: 2021

Vaccine temperature management in Lao People's Democratic Republic: A nationwide cross-sectional study

DOI: 10.1016/j.heliyon.2021.e07342

Year: 2021

How Do Infectious Agents Influence Epigenetics?

How are Zoonoses Transmitted?

Why are Some Populations More Vulnerable?

What is Plasmodium falciparum Malaria?

What is the DTaP Vaccine?

What is a Virus?

What is the Global Impact of Hepatitis B?

What are the Common Diseases Caused by Contaminated Food and Water?

What are Respiratory Symptoms?

What are the Risk Factors for Developing Dengue Hemorrhagic Fever?

Partnered Content Networks

Relevant Topics